Health

Sanyou Biopharmaceuticals and Sinorda Biomedicine signed Strategic Cooperation Agreement for Advancing Innovative Drug Research and Development

SHANGHAI, Aug. 22, 2023 /PRNewswire/ -- Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. (referred to as "Sanyou" hereafter) and Sinorda Biomedicine (referred to as " Sinorda " hereafter) have officially signed a strategic cooperation agreement to advance the innovative bispecific antibody drug pro...

2023-08-22 20:00 1743

CARsgen Announced 2023 Interim Results

SHANGHAI, Aug. 22, 2023 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announced its 2023 Interim Results. Business Highlights * Collaboration agr...

2023-08-22 19:30 3278

Ratchaphruek Hospital in Khon Kaen, Thailand Achieves GHA Accreditation with Excellence, Affirming Its World-Class Services for Medical Travelers

KHON KAEN, Thailand, Aug. 22, 2023 /PRNewswire/ -- Ratchaphruek Hospital in Khon Kaen province,Thailand, has achieved a significant milestone by being awarded Accreditation with Excellence for Medical Travel Services byGlobal Healthcare Accreditation (GHA). This accolade underscores Ratchaphruek ...

2023-08-22 18:00 1385

Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China

SUZHOU, China, Aug. 22, 2023 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced that the company has completed the enrollment of 180 patients for the Phase...

2023-08-22 17:13 1436

Berlin Heals Holding AG welcomes Dr. Felix Baader and Roland Diggelmann as new board members Final phase of ongoing CE study started

ZUG, Switzerland, Aug. 22, 2023 /PRNewswire/ -- Berlin Heals Holding AG (Berlin Heals), a Swiss medical technology company, is delighted to announce the appointments of Dr.Felix Baader and Roland Diggelmann as new members of the Board of Directors. Since 2014, the company has developed a complete...

2023-08-22 15:00 1581

Introducing NeoMab™: GemPharmatech's Innovative Antibody Gene Humanized Mouse Model

SAN DIEGO, Aug. 21, 2023 /PRNewswire/ -- GemPharmatech is proud to announce the launch of NeoMab™, our independently developed fully antibody gene humanized mouse model, after four years of rigorous research and validation. NeoMab™ is specifically designed to meet the burgeoning therapeutic antib...

2023-08-22 08:59 1408

Mammotome Launches the HydroMARK™ Plus Breast Biopsy Site Marker, an Innovation for Tissue Marker Displacement

CINCINNATI, Aug. 21, 2023 /PRNewswire/ -- Mammotome announced the launch of an innovative new HydroMARK™ Plus Breast Biopsy Site Marker designed to enhance ultrasound visibility, improve ease of locating, and mitigate displacement during surgical procedures.1,2,3,4 This device marks another great...

2023-08-21 22:00 1531

Expanse Medical Welcomes Shlomi Nachman to Board of Directors

PLEASANTON, Calif., Aug. 21, 2023 /PRNewswire/ -- Expanse Medical, the innovative medical device incubator founded by Eitan Konstantino with focus on global innovations, proudly announces the addition ofShlomi Nachman to its Board of Directors and the Board of its spinoff, Expanse ICE. Mr. Nachma...

2023-08-21 21:01 1714

Lunit Backs the Potential of Tertiary Lymphoid Structures Analysis as an Emerging Biomarker for Lung Cancer Treatment - to be presented at WCLC 2023

- A collaborative study demonstrates that AI analysis of Tertiary Lymphoid Structures (TLS) in tumors can predict treatment response in non-small cell lung cancer patients SEOUL, South Korea, Aug. 21, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for canc...

2023-08-21 21:00 2037

YGF Inc. Launches New Product Developed With 'Fire Evacuation Mask' Patent Technology

* Selected as a pilot purchase product for technology development by the Ministry of SMEs and Startups in 2023 SEOUL, South Korea, Aug. 21, 2023 /PRNewswire/ -- When fire or explosion breaks out in collective buildings or high-rise buildings, especially hospitals, and nursing facilities, which ...

2023-08-21 20:00 1250

CanariaBio Achieves Significant Milestone with FDA's Orphan Drug Designation for MAb-AR20.5 Targeting Pancreatic Cancer

The investigational monoclonal antibody becomes the first to target Mucin 1 (MUC1) and receive this designation. PYEONGTAEK, South Korea, Aug. 21, 2023 /PRNewswire/ -- CanariaBio Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative immun...

2023-08-21 20:00 1774

Zepp Health Corporation Reports Second Quarter 2023 Unaudited Financial Results

AMSTERDAM, Aug. 21, 2023 /PRNewswire/ -- Zepp Health Corporation ("Zepp" or the "Company") (NYSE: ZEPP) today reported revenues ofRMB0.65 billion (US$89.4 million); a basic and diluted net loss per share of RMB0.29 (US$0.04); and a basic and diluted net loss per ADS ofRMB1.15 (US$0.16) for the se...

2023-08-21 18:15 2342

Hummingbird Bioscience to Present Poster on HMBD-001 Combination Strategy for Squamous Non-Small Cell Lung Cancer at World Conference on Lung Cancer 2023

HOUSTON and SINGAPORE, Aug. 21, 2023 /PRNewswire/ -- Hummingbird Bioscience, a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for hard-to-treat diseases, today announced an upcoming poster presentation at the IASLC 2023 World Conference ...

2023-08-21 17:58 1469

So-Young Reports Unaudited Second Quarter 2023 Financial Results

BEIJING, Aug. 21, 2023 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics industry, today announced its unaudited financial resul...

2023-08-21 17:30 2796

magAssist's NyokAssist™️ granted Designation by the FDA as a Breakthrough Device

SUZHOU, China, Aug. 21, 2023 /PRNewswire/ -- Recently, magAssist's NyokAssist™ Interventional Ventricular Assist Device (hereinafter referred to as NyokAssist™), has been granted designation as a breakthrough device by the U.S. Food and Drug Administration (FDA) in Breakthrough Device Program. Th...

2023-08-21 14:34 2091

Everest Medicines Announces Partner Calliditas Therapeutics Receives FDA Priority Review for Full Approval of Nefecon® for the Treatment of IgA Nephropathy

SHANGHAI, Aug. 21, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company") announced today that U.S. Food and Drug Administration (FDA) has accepted the submission for the supplemental New Drug Application (sNDA) for Nefecon® from its partner Calliditas Therapeutics AB ...

2023-08-21 08:20 1980

Sisram Medical to Report H1 2023 Financial Results on August 23 and Hold a Conference Call on August 24

H1 2023 conference call to be held on August 24, at 8:00 a.m. Eastern Time HONG KONG, Aug. 20, 2023 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", stock code: 1696.HK; together with its subsidiaries referred as the " Group"), a global consumer wellness group featuring a first-of-it...

2023-08-20 10:14 3885

TradeUP Acquisition Corp. Announces Extension of the Deadline for an Initial Business Combination

NEW YORK, Aug. 18, 2023 /PRNewswire/ -- TradeUP Acquisition Corp. (the "Company" or "TradeUP") (NASDAQ: UPTD) today announced that, in order to extend the date by which the Company must complete its initial business combination fromAugust 19, 2023 to September 19, 2023, for each public share that...

2023-08-19 04:30 5164

Boryung Partners with AIAA to Host 'Humans In Space Symposium' at 2023 ASCEND

* Boryung to host HIS Symposium at 2023 ASCEND in Las Vegas this October * Over 2,000 global space experts are set to attend ASCEND, the world's premier collaborative, outcomes-driven, interdisciplinary event designed to accelerate the building of our sustainable off-world future * Boryung w...

2023-08-19 01:00 2421

3Z and biotx.ai Forge Partnership to Advance ADHD Drug Development Using AI Modelling

REYKJAVIK, Iceland and BERLIN, Aug. 18, 2023 /PRNewswire/ -- Reykjavik-based drug discovery company, 3Z, andGermany/US-based causal AI firm, biotx.ai, have joined forces in a strategic partnership aimed at revolutionizing ADHD drug development. By leveraging advanced AI modelling techniques, the ...

2023-08-18 22:45 2795
1 ... 177178179180181182183 ... 847